United States
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 29.51 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
2 |
USD 14.20 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
3 |
USD 7.78 B
|
Nov. 9, 2024 | USD 59.92 | 0.72% |
|
United States |
|
4 |
USD 4.82 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
5 |
USD 3.43 B
|
Nov. 30, 2024 | USD 20.73 | 0.34% |
|
United States |
|
6 |
USD 3.33 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
7 |
USD 2.51 B
|
Sept. 30, 2024 | USD 11.72 | -0.68% |
|
United States |
|
8 |
USD 1.84 B
|
Nov. 2, 2024 | USD 404.06 | 0.03% |
|
United States |
|
9 |
USD 1.57 B
|
Nov. 2, 2024 | USD 36.79 | 0.03% |
|
United States |
|
10 |
USD 1.06 B
|
Sept. 30, 2024 | USD 627.71 | 1.49% |
|
United States |
|
11 |
USD 811.83 M
|
Sept. 30, 2024 | USD 39.22 | 1.63% |
|
United States |
|
12 |
USD 460.00 M
|
Sept. 30, 2024 | USD 6.18 | -4.33% |
|
United States |
|
13 |
USD 407.20 M
|
Sept. 30, 2024 | USD 17.80 | 3.01% |
|
United States |
|
14 |
USD 283.53 M
|
Oct. 31, 2024 | USD 72.63 | 1.31% |
|
United States |
|
15 |
USD 278.46 M
|
Sept. 26, 2024 | USD 95.99 | -0.72% |
|
United States |
|
16 |
USD 267.66 M
|
Sept. 28, 2024 | USD 63.79 | -0.65% |
|
United States |
|
17 |
USD 193.25 M
|
Sept. 28, 2024 | USD 66.75 | 0.48% |
|
United States |
|
18 |
USD 178.00 M
|
Sept. 30, 2024 | USD 8.97 | -1.75% |
|
United States |
|
19 |
USD 146.04 M
|
Sept. 30, 2024 | USD 4.15 | -1.66% |
|
United States |
|
20 |
USD 101.45 M
|
Sept. 30, 2024 | USD 17.68 | 0.68% |
|
United States |
|
21 |
USD 71.34 M
|
Sept. 30, 2024 | USD 38.98 | 0.72% |
|
United States |
|
22 |
USD 63.95 M
|
Sept. 30, 2024 | USD 54.16 | 0.43% |
|
United States |
|
23 |
USD 55.96 M
|
Sept. 28, 2024 | USD 35.65 | -0.17% |
|
United States |
|
24 |
USD 34.29 M
|
Sept. 30, 2024 | USD 42.32 | NA |
|
United States |
|
25 |
USD 22.78 M
|
Sept. 30, 2024 | USD 14.98 | -0.13% |
|
United States |
|
26 |
USD 16.81 M
|
Sept. 30, 2024 | USD 5.67 | 2.35% |
|
United States |
|
27 |
USD 11.91 M
|
Nov. 2, 2024 | USD 11.50 | 1.23% |
|
United States |
|
28 |
USD 5.43 M
|
Sept. 30, 2024 | USD 4.88 | 0.62% |
|
United States |
|
29 |
USD 3.80 M
|
Sept. 30, 2024 | USD 12.40 | -1.20% |
|
United States |
|
30 |
USD 1.64 M
|
Sept. 30, 2024 | USD 1.64 | -2.96% |
|
United States |
|
31 |
USD -4.08 M
|
Dec. 31, 2023 | USD 3.79 | 1.24% |
|
United States |
|
32 |
USD -9.31 M
|
Sept. 30, 2024 | USD 1.05 | -7.08% |
|
United States |
|
33 |
USD -12.13 B
|
Nov. 30, 2024 | USD 12.24 | 2.86% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest EBITDA is Johnson & Johnson (NYSE: JNJ) at USD 29.51 B.
The Drugstores & Retail Pharmacies company in United States with the lowest EBITDA is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at USD -12.13 B.
The top 10 Drugstores & Retail Pharmacies companies in United States by EBITDA are Johnson & Johnson, CVS Health Corporation, The Kroger Co., McKesson Corporation, Albertsons Companies, Inc., Cencora, Viatris Inc., Ulta Beauty, Inc., Bath & Body Works, Inc. and Lennox International Inc..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by EBITDA are Walgreens Boots Alliance, Inc., Biofrontera Inc., Pilulka Lékárny a.s., Aytu BioPharma, Inc., ShotSpotter, Inc., PetMed Express, Inc., AstroNova, Inc., biote Corp., Xponential Fitness, Inc. and Omnicell, Inc..